We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$400B
AUM Growth
+$29.4B
Cap. Flow
+$10.8B
Cap. Flow %
2.7%
Top 10 Hldgs %
14.74%
Holding
7,051
New
207
Increased
2,867
Reduced
3,206
Closed
165

Sector Composition

Rank Sector Weight
1 Technology 13.16%
2 Healthcare 9.53%
3 Financials 9.25%
4 Consumer Discretionary 7.98%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRAK icon
5251
ReposiTrak
TRAK
$158M
$237K ﹤0.01%
23,489
-14,027
-37% -$118K
UPGD icon
5252
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$120M
$237K ﹤0.01%
4,902
PIR
5253
DELISTED
Pier 1 Imports, Inc.
PIR
$237K ﹤0.01%
7,901
-3,096
-28% -$123K
EPHE icon
5254
iShares MSCI Philippines ETF
EPHE
$144M
$236K ﹤0.01%
7,846
+3,221
+70% +$102K
CHRA
5255
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$236K ﹤0.01%
2,984
-75,470
-96% -$6.05M
MBII
5256
DELISTED
Marrone Bio Innovations, Inc.
MBII
$236K ﹤0.01%
128,917
+12,010
+10% +$23.3K
FSFG
5257
DELISTED
First Savings Financial Group
FSFG
$235K ﹤0.01%
10,296
-1,380
-12% -$32.1K
XERS icon
5258
Xeris Biopharma Holdings
XERS
$1.27B
$235K ﹤0.01%
13,386
+12,663
+1,751% +$275K
CSTR
5259
DELISTED
CapStar Financial Holdings, Inc
CSTR
$235K ﹤0.01%
14,074
-4,388
-24% -$79.1K
ODT
5260
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$235K ﹤0.01%
12,107
-2,486
-17% -$50.7K
CRD.B icon
5261
Crawford & Co Class B
CRD.B
$563M
$234K ﹤0.01%
25,437
-377
-1% -$3.29K
PTGX icon
5262
Protagonist Therapeutics
PTGX
$9.46B
$233K ﹤0.01%
22,637
-23,043
-50% -$198K
RES icon
5263
RPC Inc
RES
$1.31B
$233K ﹤0.01%
15,113
-1,031,358
-99% -$15.2M
HBB icon
5264
Hamilton Beach Brands
HBB
$363M
$232K ﹤0.01%
10,557
-3,729
-26% -$94.6K
DAY
5265
DELISTED
Dayforce
DAY
$232K ﹤0.01%
5,523
+3,948
+251% +$145K
EWZS icon
5266
iShares MSCI Brazil Small-Cap ETF
EWZS
$223M
$231K ﹤0.01%
19,401
-16,197
-45% -$203K
KF
5267
Korea Fund
KF
$251M
$231K ﹤0.01%
6,303
-398
-6% -$14.5K
FRTA
5268
DELISTED
Forterra, Inc
FRTA
$231K ﹤0.01%
30,957
-12,876
-29% -$111K
HOS
5269
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$231K ﹤0.01%
39,169
-9,184
-19% -$42.1K
APF
5270
DELISTED
Morgan Stanley Asia Pacific Fund
APF
$231K ﹤0.01%
13,956
-1,829
-12% -$30.8K
RDHL
5271
Redhill Biopharma
RDHL
$3.53M
$230K ﹤0.01%
26
+23
+767% +$187K
HIVE
5272
DELISTED
Aerohive Networks
HIVE
$230K ﹤0.01%
55,904
-87,295
-61% -$363K
HSTO
5273
DELISTED
Histogen Inc. Common Stock
HSTO
$229K ﹤0.01%
197
-477
-71% -$439K
CPAC
5274
Cementos Pacasmayo
CPAC
$1.02B
$228K ﹤0.01%
21,771
SCTL
5275
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$228K ﹤0.01%
35,785
-9,821
-22% -$55.6K

Similar funds

Morgan Stanley's Q3 2018 Portfolio in Review

As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,206 reduced and 165 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
  • Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
  • Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
  • Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
  • Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
  • Morgan Stanley opened 207 new positions and closed 165 in Q3 2018.
  • Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.

Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.